Search Results 1461-1470 of 13320 for monoclonal antibody
The cancer immunotherapy research focus area studies the immune system to help fight cancer. Basic scientists and clinicians work together to develop new ...
... monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy.
Use of anti-IgE (e.g., omalizumab) or any other monoclonal antibody, in the 6 months prior to randomization. Use of (Beta) β-blockers within 1 day prior to ...
Participation eligibility · History of severe allergic or anaphylactic reactions to monoclonal antibodies or known hypersensitivity to any component of the ...
Previous Treatment with a B-cell depleting antibody; History of severe allergic reactions to humanized or murine monoclonal antibodies; Treatment with any ...
Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · MRI · Positron emission tomography (PET) scan.
Abnormal specific antibody response to immunization; ... Has received any lymphocyte depleting agents including anti-CD20 monoclonal antibodies, alemtuzumab, ATG ...
The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...
Clinical Trials · CNS Autoantibody and Inflammatory Marker Investigation in Catatonia · More about research at Mayo Clinic · Mayo Clinic Footer.
- Immunotherapy (monoclonal antibodies) =< 4 weeks prior to registration - Experimental agent in case of AML or TCL within 4 half-lives of the last dose of
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.